CARVEDILOL PLUS NUCS TO PREVENT THE PROGRESSION OF ESOPHAGEAL VARICES IN VIROLOGICAL SUPPRESSED HBV-CIRRHOSIS PATIENTS: A RANDOMISED, OPEN-LABEL TRIAL

被引：0

作者：

Wang, Bingqiong ^{[1
]}

Zhou, Jialing ^{[1
]}

Wu, Xiaoning ^{[2
]}

Sun, Yameng ^{[2
]}

Li, Lei ^{[3
]}

Li, Ping ^{[4
]}

Li, Minghui ^{[5
]}

Jiang, Wei ^{[6
]}

Xu, Mingyi ^{[7
]}

Feng, Bo ^{[8
]}

Xu, Xiaoyuan ^{[9
]}

Cheng, Jilin ^{[10
]}

Xie, Wen ^{[11
]}

Han, Tao ^{[12
]}

Wang, Xiaozhong ^{[13
]}

Li, Hai ^{[14
]}

Piao, Hongxin ^{[15
]}

Zhao, Xinyu ^{[16
,17
,18
]}

Chen, Shuyan ^{[5
]}

Meng, Tongtong ^{[2
]}

Guan, Qiushuang ^{[1
]}

Meng, Fandong ^{[19
]}

Kong, Yuanyuan ^{[20
,21
]}

Ou, Xiaojuan ^{[2
]}

Jia, Jidong ^{[2
]}

You, Hong ^{[5
]}

机构：

[1] Capital Med Univ, Beijing Key Lab Translat Med Liver Cirrhosis, Natl Clin Res Ctr Digest Dis, Liver Res Ctr,Beijing Friendship Hosp, Beijing, Peoples R China

[2] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Liver Res Ctr, Beijing, Peoples R China

[3] Capital Med Univ, Beijing Youan Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China

[4] Tianjin Second Peoples Hosp, Dept Hepatol, Tianjin, Peoples R China

[5] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China

[6] Fudan Univ, Dept Gastroenterol, Zhongshan Hosp Xiamen, Xiamen 361015, Peoples R China

[7] Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol & Hepatol, Shanghai Gen Hosp, Shanghai, Peoples R China

[8] Peking Univ, Peoples Hosp, Beijing, Peoples R China

[9] Peking Univ First Hosp, Beijing, Peoples R China

[10] Shanghai Publ Hlth Clin Ctr, Dept Gastroenterol, Shanghai, Peoples R China

[11] Capital Med Univ, Beijing Ditan Hosp, Ctr Liver Dis, Beijing, Peoples R China

[12] Tianjin Med Univ, Dept Hepatol, Tianjin Cent Hosp 3, Tianjin, Peoples R China

[13] Xinjiang Med Univ, Xinjiang Hosp Tradit Chinese Med, Affiliated Hosp 4, Urumqi, Xinjiang, Peoples R China

[14] Tianjin Xiqing Hosp, Dept Gastroenterol, Tianjin, Peoples R China

[15] Yanbian Univ, Dept Infect Dis, Affiliated Hosp, Yanji, Jilin, Peoples R China

[16] Natl Clin Res Ctr Digest Dis, Dept Clin Epidemiol, Beijing, Peoples R China

[17] Natl Clin Res Ctr Digest Dis, EBM Unit, Beijing, Peoples R China

[18] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[19] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol, Beijing, Peoples R China

[20] Capital Med Univ, Beijing Friendship Hosp, Beijing Clin Res Inst, Clin Epidemiol, Beijing, Peoples R China

[21] Capital Med Univ, Beijing Friendship Hosp, Beijing Clin Res Inst, EBM Unit, Beijing, Peoples R China

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

206

引用

页码：S217 / S218

页数：2

共 50 条

[1] Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial
Wang, Bingqiong
Zhou, Jialing
Wu, Xiaoning
Sun, Yameng
Li, Lei
Li, Ping
Li, Minghui
Jiang, Wei
Xu, Mingyi
Feng, Bo
Xu, Xiaoyuan
Cheng, Jilin
Xie, Wen
Han, Tao
Wang, Xiaozhong
Li, Hai
Piao, Hongxin
Zhao, Xinyu
Chen, Shuyan
Meng, Tongtong
Guan, Qiushuang
Meng, Fandong
Kong, Yuanyuan
Ou, Xiaojuan
Jia, Jidong
You, Hong
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (04): : 700 - 711
[2] Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial
Bhardwaj, Ankit
Kedarisetty, Chandan Kumar
Vashishtha, Chitranshu
Bhadoria, Ajeet Singh
Jindal, Ankur
Kumar, Guresh
Choudhary, Ashok
Shasthry, S. M.
Maiwall, Rakhi
Kumar, Manoj
Bhatia, Vikram
Sarin, Shiv Kumar
GUT, 2017, 66 (10) : 1838 - 1843
[3] Efficacy And Safety Of Carvedilol In Patients Of Acute-On-Chronic Liver Failure With Small Or No Esophageal Varices - A Placebo Control Open Label Randomised Trial (NCT02583698)
Kainth, Sumeet
Kumar, Manoj
Choudhury, Ashok K.
Anand, Lovkesh
Jindal, Ankur
Kumar, Guresh
Jain, Priyanka
Sarin, Shiv K.
HEPATOLOGY, 2017, 66 : 83A - 83A
[4] Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
Patil, Vijay M.
Menon, Nandini
Chatterjee, Abhishek
Tonse, Raees
Choudhari, Amit
Mahajan, Abhishek
Puranik, Ameya D.
Epari, Sridhar
Jadhav, Monica
Pathak, Shruti
Peelay, Zoya
Walavalkar, Rutuja
Muthuluri, Hemanth K.
Krishna, Madala Ravi
Chandrasekharan, Arun
Pande, Nikhil
Gupta, Tejpal
Banavali, Shripad
Jalali, Rakesh
ECLINICALMEDICINE, 2022, 49
[5] Antibiotic prophylaxis to prevent infection in patients with Child-Pugh A cirrhosis with upper gastrointestinal bleed: an open label randomised controlled trial
Gupta, Anany
Agarwal, Samagra
Sharma, Sanchit
Gopi, Srikanth
Gunjan, Deepak
Saraya, Anoop
HEPATOLOGY INTERNATIONAL, 2025,
[6] Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial
Marinosci, Annalisa
Sculier, Delphine
Wandeler, Gilles
Yerly, Sabine
Stoeckle, Marcel
Bernasconi, Enos
Braun, Dominique L.
Vernazza, Pietro
Cavassin, Matthias
Buzzi, Marta
Metzner, Karin J.
Decosterd, Laurent
Guenthard, Huldrych F.
Schmid, Patrick
Limacher, Andreas
Branca, Mattia
Calmy, Alexandra
SWISS MEDICAL WEEKLY, 2024, 154
[7] Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Pirker, Robert
Pereira, Jose R.
Szczesna, Aleksandra
von Pawel, Joachim
Krzakowski, Maciej
Ramlau, Rodryg
Vynnychenko, Ihor
Park, Keunchil
Yu, Chih-Teng
Ganul, Valentyn
Roh, Jae-Kyung
Bajetta, Emilio
O'Byrne, Kenneth
de Marinis, Filippo
Eberhardt, Wilfried
Goddemeier, Thomas
Emig, Michael
Gatzemeier, Ulrich
Pirker, R.
Thatcher, N.
Armand, J. P.
Camus, P.
Victor, N.
Emig, M.
Mueser, M.
Pilz, K.
Goddemeier, T.
Montaner, I.
Lachs, Martin
Hoang-Sayag, Loan
Alvarez, A.
Coppola, F.
Recondo, G.
Richardet, E.
Kirsten, F.
Karapetis, C.
Parente, P.
Michael, M.
White, S.
Boyce, A.
Lewis, C.
Slancar, M.
Pavlakis, N.
Abdi, E.
Underhill, C.
Pittman, K.
Burghuber, O.
Pirker, R.
Ruckser, R.
Ulsperger, E.
LANCET, 2009, 373 (9674): : 1525 - 1531
[8] A Open-Label Randomised Controlled Trial of First-Line Genexol-PM/CrELBased Paclitaxel plus Cisplatin in Advanced NSCLC Patients
Han, Baohui
Wu, Yi Long
Shi, Meiqi
Gu, Aiqin
Zhang, Xueyan
Jin, Bo
Niu, Yanjie
Dong, Yu
Gu, Ping
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1083 - S1083
[9] Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Kerr, Rachel S.
Love, Sharon
Segelov, Eva
Johnstone, Elaine
Falcon, Beverly
Hewett, Peter
Weaver, Andrew
Church, David
Scudder, Claire
Pearson, Sarah
Julier, Patrick
Pezzella, Francesco
Tomlinson, Ian
Domingo, Enric
Kerr, David J.
LANCET ONCOLOGY, 2016, 17 (11): : 1543 - 1557
[10] Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
Mateos, Maria-Victoria
Blacklock, Hilary
Schjesvold, Fredrik
Oriol, Albert
Simpson, David
George, Anupkumar
Goldschmidt, Hartmut
Larocca, Alessandra
Chanan-Khan, Asher
Sherbenou, Daniel
Avivi, Irit
Benyamini, Noam
Iida, Shinsuke
Matsumoto, Morio
Suzuki, Kenshi
Ribrag, Vincent
Usmani, Saad Z.
Jagannath, Sundar
Ocio, Enrique M.
Rodriguez-Otero, Paula
San Miguel, Jesus
Kher, Uma
Farooqui, Mohammed
Liao, Jason
Marinello, Patricia
Lonial, Sagar
LANCET HAEMATOLOGY, 2019, 6 (09): : E459 - E469

← 1 2 3 4 5 →